Chemotherapy-Induced Nausea and Vomiting (CINV): 
Strategies for Optimizing Oncology Nursing Care

Provided by

American Academy of CME, Inc.

Support for this activity has been made possible through an educational grant from Eisai.


Release date:
November 30, 2015
Expiration date:
July 30, 2016
Estimated time to complete:
0.5 hr.
Activity URL:
www.academycme.org
 

Activity Description

Chemotherapy-Induced Nausea and Vomiting (CINV): Strategies for Optimizing Oncology Nursing Care is a free, case-based, online activity designed to improve the knowledge and competence of oncology nursing professionals who care for patients with or who are at risk of developing chemotherapy induced nausea and vomiting (CINV). As the etiology of CINV has been better defined, advances have been made in prevention and management of this common side effect. While new agents have expanded treatment options, novel agents are still needed, especially in the areas of delayed, breakthrough, and refractory symptoms, the management of nausea, and the treatment of patients who receive multiday chemotherapy. Some of these issues may be addressed by implementing new dosing strategies and regimens using currently available agents. Education is needed to increase awareness that the problem of CINV continues in many patients and to improve knowledge about available treatments and guidelines and how to apply them.

Activity Faculty

Beth Eaby-Sandy, MSN, CRNP, OCN
Outpatient Thoracic Oncology Nurse Practitioner, CRNP
University of Pennsylvania Health System, Philadelphia, PA

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and nurse practitioners. Other healthcare professionals may also participate

Learning Objectives

After completing this activity, learners should be better able to:

  • Perform pretreatment assessments of patient-specific and regimen-specific risk factors for CINV

  • Make recommendations for the prevention of CINV based upon assessments and current management options

Accreditation and Credit Designation

Nurses
American Academy of CME, Inc, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

American Academy of CME, Inc., designates this educational activity for 0.5 contact hours. (0.5 pharmacotherapeutic contact hours)

Disclosure Statement
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows: 

Faculty
Beth Eaby-Sandy, MSN, CRNP, OCN discloses the following:
Advisory board – marketing purposes for Clovis Oncology
Advisory board – for scientific information for AstraZeneca
Consultant – for marketing purposes for Boehringer Ingelheim
Promotional speaker’s bureaus – for Amgen, Merck, Celgene, Eisai

Planning Committee
Wendy Gloffke, PhD, John JD Juchniewicz, MCIS, CHCP, Paul J. Minter MS, and Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, American Academy of CME: No relevant financial relationships with any commercial interests.

Independent External Reviewer
Jo-Ann Stankus, BSN, MSN, MA, Ph.D, Assistant Professor, College of Nursing, Texas Woman’s University. The following has been disclosed: shareholder in General Electric, Johnson & Johnson, Monsanto Co New, Novartis and Shire.

This presentation discusses non FDA approved use of glucocorticoids, metoclopramide, olanzapine, lorazepam, alprazolam, midazolam, prochlorperazine, and haloperidol for chemotherapy-induced nausea and vomiting.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks.  If asked, the activity ID is 15AA0700. Your certificate can be printed immediately.

Hardware/Software Requirements

This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, or Safari. A high-speed Internet connection is recommended.

You must have the Adobe Flash Player 10 or higher installed on your computer in order to view this program. If you do not have the Adobe Flash Player, you can download this free plug-in from Adobe.com.

Privacy

For more information about the American Academy of CME, Inc. privacy policy, please access http://www.academycme.org/privacy.htm.

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2015. This CNE-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy  grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Proceed to Activity